A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis Meeting Abstract

  

Authors:	Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; Li, J.; Zervoudakis, A.; Hamilton, A.; Won, E.; Do, R. K. G.; O'Reilly, E. M.
Abstract Title:	A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
Meeting Title:	43rd ESMO Congress (ESMO 2018)
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 8
Meeting Dates:	2018 Oct 19-23
Meeting Location:	Munich, Germany
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-10-01
Start Page:	mdy287.002
Language:	English
ACCESSION:	WOS:000459277301309
PROVIDER:	wos
DOI:	10.1093/annonc/mdy282.113
Notes:	Meeting Abstract: 730P -- Appears on page viii248 of the abstract book -- Source: Wos